As of 2025-07-03, the Relative Valuation of Appili Therapeutics Inc (APLI.TO) is (1.20) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.02 CAD, the upside of Appili Therapeutics Inc based on Relative Valuation is -8114.4%.
The range of the Relative Valuation is (1.14) - (1.22) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 29.9x - 37.5x | 33.7x |
| Forward P/E multiples | 34.9x - 45.1x | 40.0x |
| Fair Price | (1.14) - (1.22) | (1.20) |
| Upside | -7699.0% - -8247.1% | -8114.4% |
| Date | P/E |
| 2025-06-30 | -0.46 |
| 2025-06-27 | -0.46 |
| 2025-06-26 | -0.46 |
| 2025-06-25 | -0.46 |
| 2025-06-24 | -0.46 |
| 2025-06-23 | -0.31 |
| 2025-06-17 | -0.46 |
| 2025-06-16 | -0.46 |
| 2025-06-13 | -0.46 |
| 2025-06-12 | -0.46 |
| 2025-06-11 | -0.46 |
| 2025-06-10 | -0.46 |
| 2025-06-06 | -0.46 |
| 2025-06-05 | -0.46 |
| 2025-06-04 | -0.46 |
| 2025-06-03 | -0.46 |
| 2025-06-02 | -0.61 |
| 2025-05-29 | -0.46 |
| 2025-05-28 | -0.61 |
| 2025-05-27 | -0.61 |
| 2025-05-26 | -0.46 |
| 2025-05-23 | -0.46 |
| 2025-05-22 | -0.46 |
| 2025-05-21 | -0.46 |
| 2025-05-20 | -0.61 |
| 2025-05-14 | -0.92 |
| 2025-05-12 | -0.92 |
| 2025-05-09 | -0.92 |
| 2025-05-08 | -1.07 |
| 2025-05-07 | -0.92 |
| 2025-05-06 | -0.92 |
| 2025-05-05 | -0.92 |
| 2025-05-02 | -1.07 |
| 2025-05-01 | -0.92 |
| 2025-04-30 | -0.92 |
| 2025-04-28 | -0.92 |
| 2025-04-25 | -0.92 |
| 2025-04-24 | -0.77 |
| 2025-04-21 | -0.92 |
| 2025-04-17 | -0.92 |
| 2025-04-16 | -0.77 |
| 2025-04-14 | -0.92 |
| 2025-04-09 | -0.92 |
| 2025-04-08 | -0.77 |
| 2025-04-04 | -0.92 |